Enzo IP Suits Against Affy, Roche, Others Move Forward as Court Hands Down Summary Judgment | GenomeWeb

A decade-old string of lawsuits that has embroiled seven life sciences firms is closer to resolution following a recent ruling.

Judge Richard Sullivan of the US District Court of the Southern District of New York on Sept. 21 granted in part and denied in part combined and individual motions from Affymetrix, Amersham, Molecular Probes, Orchid Biosciences, PerkinElmer, and Roche Diagnostics for summary judgment, ruling that they do not infringe IP owned by Enzo Biochem and its wholly owned subsidiary Enzo Life Sciences.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

Widespread genome sequencing might not be justified just yet, USA Today reports.